XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 106 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $395,412 | +1.8% | 175,739 | -0.0% | 0.01% | -8.3% |
| Q1 2024 | $388,389 | +6.2% | 175,741 | +12.9% | 0.01% | 0.0% |
| Q4 2023 | $365,777 | +12.1% | 155,650 | -11.3% | 0.01% | 0.0% |
| Q3 2023 | $326,257 | -29.0% | 175,407 | 0.0% | 0.01% | -29.4% |
| Q2 2023 | $459,566 | +81.1% | 175,407 | +12.7% | 0.02% | +70.0% |
| Q1 2023 | $253,709 | +122464.7% | 155,650 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $207 | -99.9% | 155,650 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $243,000 | +1.2% | 155,650 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $240,000 | -39.7% | 155,650 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $398,000 | -12.7% | 155,650 | 0.0% | 0.01% | -6.7% |
| Q4 2021 | $456,000 | – | 155,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |